BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference

Group 1 - BioSyent Inc. will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference in Toronto on May 5 and 6, 2025 [1] - Mr. René Goehrum, President and CEO, will provide an overview of the company's business and corporate activities on May 5 at 11:30am EDT [1] - One-on-one meetings with Mr. Goehrum can be scheduled by registered attendees through the conference portal [2] Group 2 - BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative healthcare products [3] - The company supports healthcare professionals by marketing its products through community, specialty, and international business units [3] - As of the press release date, BioSyent has 11,254,638 common shares outstanding [4]